Details for New Drug Application (NDA): 086504
✉ Email this page to a colleague
NDA 086504 describes HYDRO-D, which is a drug marketed by Halsey and is included in two NDAs. Additional details are available on the HYDRO-D profile page.
The generic ingredient in HYDRO-D is hydrochlorothiazide. There are thirty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide profile page.
The generic ingredient in HYDRO-D is hydrochlorothiazide. There are thirty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide profile page.
Summary for 086504
| Tradename: | HYDRO-D |
| Applicant: | Halsey |
| Ingredient: | hydrochlorothiazide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086504
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
